Presentation
Nathalie Lefort has a 15-year experience in human pluripotent stem cell (hPSC) culture and their application for pathological modeling and cell therapy. She worked for 10 years in I-Stem Institute (Institute for Stem cell Therapy and Exploration of Monogenic diseases), pioneer in France in the field of hPSCs. Her work has raised the concern about genetic alteration and contributed to the discovery of a recurrent duplication in hPSCs as well as to the identification of a recurrent translocation occurring in neural derivatives of hPSC. Since july 2015, Nathalie Lefort has established the IPSC core facility of the Imagine Institute. The iPSC core facility allows the development of new cellular models for the study of rare diseases
Resources & publications
-
Journal (source)Proc. Natl. Acad. Sci. U.S.A.
Striatal progenitors derived from human ES cells mature into DARPP32 neurons ...
-
Journal (source)Nat. Biotechnol.
Human embryonic stem cells reveal recurrent genomic instability at 20q11.21.
-
Journal (source)Regen Med
Human embryonic stem cells and genomic instability.
-
Journal (source)J. Clin. Invest.
Recurrent genomic instability of chromosome 1q in neural derivatives of human...
-
Journal (source)Hum. Mol. Genet.
Early transcriptional changes linked to naturally occurring Huntington's dise...
-
Journal (source)Elife
High N-glycan multiplicity is critical for neuronal adhesion and sensitizes t...
-
Journal (source)Stem Cell Res
Generation of an induced pluripotent stem cell (iPSC) line (IMAGINi007) from ...
-
Journal (source)Stem Cell Res
Generation of an iPSC line (IMAGINi022-A) from a patient carrying a SOX10 mis...
-
Journal (source)Stem Cell Res
Generation of two induced pluripotent stem cell lines IMAGINi004-A and IMAGIN...
-
Journal (source)Nat Commun
MINPP1 prevents intracellular accumulation of the chelator inositol hexakisph...